Cutaneous cylindroma: it's all about MYB

Journal of Pathology

Volumn 239, Issue 4, 2016, Pages 391-393

  Corda, Gabriele ^a   Sala, Arturo ^a  

^a BRUNEL UNIVERSITY   (United Kingdom)

Author keywords

adenoid cystic carcinoma; Brooke Spiegler syndrome; CYLD; cylindroma; MYB

Indexed keywords

GIVINOSTAT; HISTONE ACETYLTRANSFERASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN MYB; RIGOSERTIB;

ADENOID CYSTIC CARCINOMA; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BROOKE SPIEGLER SYNDROME; CUTANEOUS CYLINDROMA; CYLD GENE; DRUG MECHANISM; EPIDERMIS CELL; FAMILIAL CANCER; GENE EXPRESSION; GENE FUSION; GENE MUTATION; GENE REARRANGEMENT; HISTONE ACETYLATION; HUMAN; NOTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE; SKIN CARCINOGENESIS; SKIN TUMOR; TUMOR SUPPRESSOR GENE; WILD TYPE;

EID: 84979294071     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4746     Document Type: Note

References (18)

1. Bignell GR, Warren W, Seal S, et al. Identification of the familial cylindromatosis tumour-suppressor gene. Nat Genet 2000; 25: 160–165.
2. Leonard N, Chaggar R, Jones C, et al. Loss of heterozygosity at cylindromatosis gene locus, CYLD, in sporadic skin adnexal tumours. J Clin Pathol 2001; 54: 689–692.
3. Fehr A, Kovacs A, Löning T, et al. The MYB–NFIB gene fusion – a novel genetic link between adenoid cystic carcinoma and dermal cylindroma. J Pathol 2011; 224: 322–327.
4. Ramsay RG, Gonda TJ. MYB function in normal and cancer cells. Nat Rev Cancer 2008; 8: 523–534.
5. Bandopadhayay P, Ramkissoon LA, Jain P, et al. MYB–QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism. Nat Genet 2016; 48: 273–282.
6. Gualdrini F, Corvetta D, Cantilena S, et al. Addiction of MYCN amplified tumours to B-MYB underscores a reciprocal regulatory loop. Oncotarget 2010; 1: 278–288.
7. Zhou Y, Ness SA. Myb proteins: angels and demons in normal and transformed cells. Front Biosci 2011; 16: 1109–1131.
8. Calvisi DF, Simile MM, Ladu S, et al. Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)–LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53. Hepatology 2011; 53: 1226–1236.
9. Persson M, Andrén Y, Mark J, et al. Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck. Proc Natl Acad Sci USA 2009; 106: 18740–18744.
10. Drier Y, Cotton MJ, Williamson KE, et al. An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma. Nat Genet 2016; 48: 265–272.
11. Rajan N, Andersson MK, Sinclair N, et al. Overexpression of MYB drives proliferation of CYLD-defective cylindroma cells. J Pathol 2016; 239: 197–205.
12. Biggs PJ, Chapman P, Lakhani SR, et al. The cylindromatosis gene (cyld1) on chromosome 16q may be the only tumour suppressor gene involved in the development of cylindromas. Oncogene 1996; 12: 1375–1377.
13. Brummelkamp TR, Nijman SM, Dirac AM, et al. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kB. Nature 2003; 424: 797–801.
14. Suhasini M, Pilz RB. Transcriptional elongation of c-myb is regulated by NF-kB (p50/RelB). Oncogene 1999; 18: 7360–7369.
15. Pannem RR, Dorn C, Hellerbrand C, et al. Cylindromatosis gene CYLD regulates hepatocyte growth factor expression in hepatic stellate cells through interaction with histone deacetylase 7. Hepatology 2014; 60: 1066–1081.
16. Yang Y, Ran J, Liu M, et al. CYLD mediates ciliogenesis in multiple organs by deubiquitinating Cep70 and inactivating HDAC6. Cell Res 2014; 24: 1342–1353.
17. Dai Y, Hung L, Chen R, et al. ON01910.Na inhibits growth of diffuse large B-cell lymphoma by cytoplasmic sequestration of sumoylated C-MYB/TRAF6 complex. Transl Res 2016; DOI: 10.1016/j.trsl.2016.04.001.
18. Sun S. CYLD: a tumor suppressor deubiquitinase regulating NF-kB activation and diverse biological processes. Cell Death Differ 2010; 17: 25–34.